genesequencing
Latest
Medicare now covers gene sequencing for patients with advanced cancer
Patients with advanced cancer will soon have access to more personalized treatment plans because Medicare will now cover genetic tests that sequence tumor cell DNA and help healthcare providers determine treatment strategies. As Wired reports, the Centers for Medicare & Medicaid Services (CMS) announced that for Medicare-enrolled patients with recurrent, metastatic, relapsed, refractory or stages III or IV cancer, such FDA-approved tests will be covered by their insurance. And since other insurance companies tend to take their cues from CMS, privately-insured patients will likely get similar coverage soon as well.
23andMe stops work on advanced gene sequencing
The team at 23andMe is dialing back some of its grander plans for DNA analysis. Co-founder Anne Wojcicki has confirmed to BuzzFeed News that her company has stopped working on next-generation sequencing that would reveal much more about your genes, such as the potential for some diseases. The executive is quick to stress that this isn't due to financial or regulatory trouble -- rather, it's a question of whether or not that data is useful enough to warrant 23andMe stretching itself thin at this point. The firm would rather focus on its "core business" right now, Wojcicki says.